Welcome to our dedicated page for QumulusAI SEC filings (Ticker: QMLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QumulusAI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QumulusAI's regulatory disclosures and financial reporting.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. MULICA MICHAEL C reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that director Michael C. Mulica received two grants of 9,583 shares each of common stock in the form of restricted stock unit awards on September 1, 2026. One award has a multi-year vesting schedule tied to continued service as a director.
The first award vests as to 3,162 shares on October 1, 2026 and as to 8.375% of the remaining shares quarterly over eight quarters starting January 1, 2027. The second award vests in full on October 1, 2026. Footnotes state that 19,166 shares are scheduled to be issued upon future vesting, conditioned on continued board service.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Glickler Andrew Mark reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that its SVP, Finance, Andrew Mark Glickler received two equity awards of common stock in RSU form totaling 70,273 shares under the QumulusAI, Inc. 2026 Equity Incentive Plan. One award of 12,777 shares begins vesting on March 1, 2027, and the other of 57,496 shares begins vesting on September 1, 2027, in each case subject to continued employment through the applicable vesting dates.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Chatterjee Ankur reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that Chief Integration Officer Ankur Chatterjee received three equity grants of common stock on September 1, 2026, all at a reported price of $0.00 per share as compensation awards. The grants are in the form of restricted stock unit awards under the QumulusAI, Inc. 2026 Equity Incentive Plan, with time-based vesting schedules extending through 2029, conditioned on his continued employment. In addition, 28,811 shares of common stock are reported as held indirectly through Kesston Group, LLC.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Krosnowski Scott Carroll reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that Chief Financial Officer Scott Carroll Krosnowski received four grants of common stock awards on September 1, 2026, all at a stated price of $0.00 per share, as compensation awards. These restricted stock unit-based grants have time-based vesting schedules running from September 1, 2026 through at least August 24, 2027 under the QumulusAI, Inc. 2026 Equity Incentive Plan, and footnotes state that 195,917 shares are scheduled to be issued upon future vesting, conditioned on continued employment.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. RENCH DAVID reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) director David Rench reported receiving two equity awards of 9,583 shares of common stock each on September 1, 2026, both at a stated price of $0.00 per share, as restricted stock unit awards under the QumulusAI, Inc. 2026 Equity Incentive Plan. One award vests as to 3,162 shares on October 1, 2026 and as to 8.375% of the remaining shares quarterly over eight quarters starting January 1, 2027, conditioned on his continued board service. The other award vests in full on October 1, 2026. As of this reporting, Rench also has 19,166 shares to be issued upon future vesting of restricted stock units and holds 47,000 shares indirectly through Rench Family Holdings, LLC.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Schwartz Barry Paul reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that director Barry Paul Schwartz received two equity awards covering a total of 19,166 shares of Common Stock on September 1, 2026, at $0.00 per share, as part of restricted stock unit awards under the QumulusAI, Inc. 2026 Equity Incentive Plan.
One 9,583-share award vests as to 3,162 shares on October 1, 2026 and as to 8.375% of the remaining shares quarterly over eight quarters commencing January 1, 2027, conditioned on Schwartz remaining a director through each vesting date. The other 9,583-share award vests in full on October 1, 2026 under the same plan. No Rule 10b5-1 trading plan is reported for these awards.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Akbari Dr. Homaira reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that director Dr. Homaira Akbari received two equity awards of common stock on September 1, 2026. One award covers 9,583 restricted stock units vesting partly on October 1, 2026 and then quarterly, and another award covers 6,038 restricted stock units vesting on October 1, 2026. After these grants, Dr. Akbari has 15,621 shares subject to vesting under the company’s 2026 Equity Incentive Plan, with no Rule 10b5-1 trading plan noted.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Gahan Patrick Joseph reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that director Gahan Patrick Joseph received four equity grants of common stock on September 1, 2026, as compensation awards (48,552; 166,237; 60,690; and 19,421 shares), each structured as restricted stock units with multi-date vesting schedules under the company’s 2026 Equity Incentive Plan.
The filing also lists indirect holdings of common stock through several entities and trusts, including 103,488 shares by Slim Mint Group LLC and 212,394 shares by Window Macaroni Group LLC, as of September 1, 2026. No Rule 10b5-1 trading plan is reported and no sales are disclosed.
QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. DiRocco Ryan Anthony reported acquisition or exercise transactions in this Form 4 filing.
QumulusAI, Inc. (QMLS) reported that Chief Technology Officer Ryan Anthony DiRocco received three equity awards of 85,179, 94,313, and 9,737 shares of common stock on September 1, 2026, all granted at no cash cost as restricted stock units under the 2026 Equity Incentive Plan and subject to multi‑year service-based vesting schedules.
After these awards, his reported holdings include 167,934 shares subject to future vesting and 33,334 shares held indirectly through RAD Corporate Holdings Inc.; the transactions are not reported as made under a Rule 10b5‑1 trading plan.
QumulusAI, Inc. (QMLS) reported that director Stacy James Kenworthy acquired two grants of common stock in the form of restricted stock units on September 1, 2026. One award covers 5,989 shares, and a second award covers 9,583 shares, both under the QumulusAI, Inc. 2026 Equity Incentive Plan.
For the 5,989-share award, 1,976 shares vest on October 1, 2026, with 8.375% of the remaining shares vesting quarterly over eight quarters starting January 1, 2027, conditioned on continued board service. The 9,583-share award vests on October 1, 2026, and footnotes state that 15,572 shares are scheduled to be issued upon future vesting of the director’s equity awards.